ADMA Biologics, Inc.
ADMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $103 | $51 | $87 | $51 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $50 | $27 | $16 | $29 |
| Inventory | $170 | $173 | $163 | $125 |
| Other Curr. Assets | $8 | $5 | $5 | $4 |
| Total Curr. Assets | $331 | $257 | $270 | $209 |
| Property Plant & Equip (Net) | $63 | $63 | $69 | $58 |
| Goodwill | $4 | $4 | $4 | $4 |
| Intangibles | $0 | $0 | $1 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $84 | $0 | $0 | $0 |
| Other NC Assets | $6 | $5 | $5 | $4 |
| Total NC Assets | $157 | $72 | $78 | $68 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $489 | $329 | $348 | $276 |
| Liabilities | – | – | – | – |
| Payables | $20 | $16 | $13 | $12 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $33 | $25 | $17 |
| Total Curr. Liab. | $56 | $50 | $39 | $30 |
| LT Debt | $81 | $140 | $154 | $102 |
| Deferred Rev, NC | $2 | $2 | $2 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $0 |
| Total NC Liab. | $84 | $144 | $157 | $105 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $11 | $12 | $8 |
| Total Liabilities | $140 | $194 | $196 | $135 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$309 | -$506 | -$478 | -$412 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $658 | $641 | $630 | $553 |
| Total Equity | $349 | $135 | $152 | $141 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $489 | $329 | $348 | $276 |
| Net Debt | -$21 | $90 | $68 | $52 |